Cargando…
Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells
Auranofin (AF), a gold (I)-containing phosphine compound, is being investigated for oncological application as a repurposed drug. We show here that 4~5 µM AF induces paraptosis, a non-apoptotic cell death mode characterized by dilation of the endoplasmic reticulum (ER) and mitochondria, in breast ca...
Autores principales: | Seo, Min Ji, Kim, In Young, Lee, Dong Min, Park, Yeon Jung, Cho, Mi-Young, Jin, Hyo Joon, Choi, Kyeong Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852458/ https://www.ncbi.nlm.nih.gov/pubmed/36658130 http://dx.doi.org/10.1038/s41419-023-05586-6 |
Ejemplares similares
-
PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca(2+) Imbalance
por: Lee, Hong-Jae, et al.
Publicado: (2022) -
Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis
por: Lee, Dong Min, et al.
Publicado: (2017) -
Intracellular Ca(2 +) Imbalance Critically Contributes to Paraptosis
por: Kim, Eunhee, et al.
Publicado: (2021) -
Auranofin, a thioredoxin reductase inhibitor, causes platelet death through calcium overload
por: Harper, Matthew T.
Publicado: (2017) -
Auranofin Inhibition of Thioredoxin Reductase in a Preclinical Model of Small Cell Lung Cancer
por: Johnson, Spenser S., et al.
Publicado: (2023)